Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Lysogene Appoints Chief Scientific Officer

Executive Summary

Lysogene, a biotech company specialising in the treatment of central nervous system diseases, has appointed Kimberley S. Gannon chief scientific officer. Gannon joins the business from NeuroPhage Pharmaceuticals Inc., where she was senior vice president of preclinical research and development. Prior to this, she held several leadership positions at other companies, including vice president of research and development at CereMedix, and senior director of biology at EPIX (Predix) Pharmaceuticals. Her expertise spans preclinical pharmacology, translational medicine and nonclinical drug development.





Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts